Camlin Fine Sciences has entered into a joint venture (JV) agreement with Pahang Pharma (S), a company duly incorporated under the laws of Singapore. The proposed term of the joint venture is 30 years with investment in holding company in the proportion of 51% by the company and 49% by Pahang Pharma (S).
The purpose of entering into agreement is for incorporating a company in Singapore who shall be holding company for its subsidiary(ies) which shall be incorporated in ASEAN countries as per the business model basically to engage in research, development, production, trade and dealing in animal feed ingredients and animal feed nutrition products viz. Antioxidants, binders, acidifiers, stabilizers, disinfectants etc.
Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).
| Company Name | CMP |
|---|---|
| BASF India | 3640.10 |
| Tata Chemicals | 809.45 |
| SRF | 2519.20 |
| Pidilite Inds. | 1375.55 |
| Deepak Nitrite | 1736.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: